文献速递糖尿病

糖尿病预防计划中与糖尿病发病相关的微小RNA

MicroRNAs Associated With Incident Diabetes in the Diabetes Prevention Program.
PubMed 文献 · J Clin Endocrinol Metab · 2023-01-01

本研究为糖尿病预防计划(DPP)队列的二次分析(n=1000),利用储存生物样本测量微小RNA(miR),用随机生存森林和Lasso方法筛选预测因子,Cox比例风险模型分析。识别出5种miR(miR-144、miR-186、miR-203a、miR-205、miR-206)为发病T2D的最优预测因子(HR 2.81,95%CI 2.05-3.87;P<.001)。

要点

  • 5种miR组合预测2型糖尿病发病的HR为2.81(95%CI 2.05-3.87;P<.001)。
  • 最高四分位风险组较低四分位风险组的HR为5.91(95%CI 2.02-17.3;P<.001)。
  • 强化生活方式与二甲双胍组间存在显著交互作用(HR分别为3.60和2.72)。

核心结论

  • 在DPP队列中识别出5种miR(miR-144、miR-186、miR-203a、miR-205、miR-206)是发病T2D的最优预测因子。

研究设计与样本

  • 本研究为糖尿病预防计划(DPP)试验的二次分析,纳入1000例DPP队列子集,利用储存生物样本测量miR。

主要发现

  • 经协变量调整后,5种miR组合预测发病T2D的HR为2.81(95%CI 2.05-3.87;P<.001)。
  • 交叉验证后,最高四分位风险组较低四分位风险组的HR为5.91(95%CI 2.02-17.3;P<.001)。
  • 强化生活方式干预组与安慰剂组相比存在显著交互作用(HR 3.60,95%CI 2.50-5.18;P<.001)。
  • 二甲双胍组与安慰剂组相比存在显著交互作用(HR 2.72,95%CI 1.47-5.00;P=.001)。
  • 5种miR中有1种靶向的基因与既往已知的T2D风险相关。

临床怎么用

  • 作者指出未来方向包括在独立样本中验证该发现,以确定该风险评分对糖尿病前期个体风险分层是否具有潜在临床效用,并对风险评分中miR靶向的潜在基因和通路进行功能分析。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: MicroRNAs (miRs) are short (ie, 18-26 nucleotide) regulatory elements of messenger RNA translation to amino acids. OBJECTIVE: The purpose of this study was to assess whether miRs are predictive of incident type 2 diabetes (T2D) in the Diabetes Prevention Program (DPP) trial. METHODS: This was a secondary analysis (n = 1000) of a subset of the DPP cohort that leveraged banked biospecimens to measure miRs. We used random survival forest and Lasso methods to identify the optimal miR predictors and the Cox proportional hazards to model time to T2D overall and within intervention arms. RESULTS: We identified 5 miRs (miR-144, miR-186, miR-203a, miR-205, miR-206) that constituted the optimal predictors of incident T2D after adjustment for covariates (hazard ratio [HR] 2.81, 95% CI 2.05, 3.87; P < .001). Predictive risk scores following cross-validation showed the HR for the highest quartile risk group compared with the lowest quartile risk group was 5.91 (95% CI 2.02, 17.3; P < .001). There was significant interaction between the intensive lifestyle (HR 3.60, 95% CI 2.50, 5.18; P < .001) and the metformin (HR 2.72; 95% CI 1.47, 5.00; P = .001) groups compared with placebo. Of the 5 miRs identified, 1 targets a gene with prior known associations with risk for T2D. CONCLUSION: We identified 5 miRs that are optimal predictors of incident T2D in the DPP cohort. Future directions include validation of this finding in an independent sample in order to determine whether this risk score may have potential clinical utility for risk stratification of individuals with prediabetes, and functional analysis of the potential genes and pathways targeted by the miRs that were included in the risk score.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Flowers E, Aouizerat BE, Kanaya AM, et al. MicroRNAs Associated With Incident Diabetes in the Diabetes Prevention Program. J Clin Endocrinol Metab. 2023. PMID: 36477577. doi:10.1210/clinem/dgac714

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。